Location: Menlo Park, CA
CIK: 0001819257 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $564M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ROIV | ROIVANT SCIENCES LTD | 8,166,047 | $226M | 40.1% | $7.21 | +235.1% | SHS | G76279101 |
| ARGX | ARGENX SE | 36,718 | $26.81M | 4.8% | $686.33 | — | SPONSORED ADR | 04016X101 |
| INSM | INSMED INC | 157,500 | $25.75M | 4.6% | $73.51 | +116.3% | COM PAR $.01 | 457669307 |
| ONC | BEONE MEDICINES LTD | 80,542 | $23.92M | 4.2% | $302.86 | — | SPONSORED ADS | 07725L102 |
| COGT | COGENT BIOSCIENCES INC | 596,000 | $22.94M | 4.1% | $32.44 | +15.2% | COM | 19240Q201 |
| MIRM | MIRUM PHARMACEUTICALS INC | 230,000 | $21.25M | 3.8% | $62.11 | +55.5% | COM | 604749101 |
| BLTE | BELITE BIO INC | 116,684 | $18.6M | 3.3% | $159.44 | — | SPONSORED ADS | 07782B104 |
| LEGN | LEGEND BIOTECH CORP | 990,000 | $17.91M | 3.2% | $18.09 | — | SPONSORED ADS | 52490G102 |
| NKTR | NEKTAR THERAPEUTICS | 210,000 | $15.11M | 2.7% | $48.33 | 0.0% | COM NEW | 640268306 |
| DBVT | DBV TECHNOLOGIES S A | 693,534 | $14.49M | 2.6% | $20.00 | — | SPONSORED ADS | 23306J309 |
| PHVS | PHARVARIS N V | 493,000 | $13.93M | 2.5% | $21.02 | +27.2% | COM | N69605108 |
| ABVX | ABIVAX SA | 121,245 | $13.5M | 2.4% | $84.90 | — | SPONSORED ADS | 00370M103 |
| XENE | XENON PHARMACEUTICALS INC | 227,000 | $13.2M | 2.3% | $41.99 | -0.0% | COM | 98420N105 |
| CELC | CELCUITY INC | 95,000 | $10.84M | 1.9% | $47.06 | +128.4% | COM | 15102K100 |
| EYPT | EYEPOINT INC | 795,000 | $10.25M | 1.8% | $8.84 | +72.2% | COM NEW | 30233G209 |
| MRK | MERCK & CO INC | 80,000 | $9.623M | 1.7% | $114.28 | 0.0% | COM | 58933Y105 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 400,645 | $9.439M | 1.7% | $26.20 | +2.5% | COM | 03969K108 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3,450,000 | $8.418M | 1.5% | $1.76 | -1.0% | COM | 019770106 |
| KYMR | KYMERA THERAPEUTICS INC | 100,000 | $8.329M | 1.5% | $46.83 | +65.7% | COM | 501575104 |
| DNTH | DIANTHUS THERAPEUTICS INC | 93,882 | $7.879M | 1.4% | $27.76 | +71.4% | COM | 252828108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 200,000 | $7.84M | 1.4% | $23.51 | +8.9% | COM | 29337E102 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 1,625,000 | $6.776M | 1.2% | $3.32 | +15.6% | COM NEW | 46489V302 |
| DFTX | DEFINIUM THERAPEUTICS INC | 331,000 | $6.256M | 1.1% | $16.29 | 0.0% | COM SHS | 24477V105 |
| HROW | HARROW INC | 165,209 | $5.825M | 1.0% | $47.86 | +0.5% | COM | 415858109 |
| TARA | PROTARA THERAPEUTICS INC | 1,030,846 | $5.371M | 1.0% | $6.18 | 0.0% | COM STK | 74365U107 |
| CTMX | CYTOMX THERAPEUTICS INC. | 1,085,790 | $5.103M | 0.9% | $5.23 | 0.0% | COM | 23284F105 |
| RCUS | ARCUS BIOSCIENCES INC | 195,000 | $4.212M | 0.7% | $20.51 | +3.7% | COM | 03969F109 |
| ASMB | ASSEMBLY BIOSCIENCES INC | 136,315 | $3.783M | 0.7% | $22.39 | +27.3% | COM NEW | 045396207 |
| SYRE | SPYRE THERAPEUTICS INC | 1,000 | $50,440 | 0.0% | $26.13 | +32.2% | COM NEW | 00773J202 |